PMGC HOLDINGS INC. Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax
PMGC HOLDINGS INC. (ELAB) reported Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax of -$1.01 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax · last filed 2024-11-14
- PMGC HOLDINGS INC. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2024-09-30 was -$1.01K, a 362.02% decline year-over-year.
- PMGC HOLDINGS INC. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2024-06-30 was -$141.00, a 153.82% decline year-over-year.
- PMGC HOLDINGS INC. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2024-03-31 was $1.18K, a 945.13% increase year-over-year.
- PMGC HOLDINGS INC. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2023-09-30 was $387.00.
| Period end | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 3 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 6 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 9 month |
|---|---|---|---|
| 2024-09-30 | -$1.01K 10-Q · filed 2024-11-14 | -$1.16K derived: sum of 2 quarters · filed 2024-11-14 | $26.00 10-Q · filed 2024-11-14 |
| 2024-06-30 | -$141.00 10-Q · filed 2024-08-14 | $1.04K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $1.18K 10-Q · filed 2024-05-15 | ||
| 2023-09-30 | $387.00 10-Q · filed 2024-11-14 | $649.00 derived: sum of 2 quarters · filed 2024-11-14 | $762.00 10-Q · filed 2024-11-14 |
| 2023-06-30 | $262.00 10-Q · filed 2024-08-14 | $375.00 10-Q · filed 2024-08-14 | |
| 2023-03-31 | $113.00 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |